Extended Data Table 1 Summary of location of genetic pathogenic variants (modified intent-to-treat population)

From: AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial

  1. aIntrons are grouped based on the nearest exon category.
Back to article page